Investors in Netherlands

Icecat Capital is the dedicated investment arm of Icecat N.V., a publicly listed company on the Dutch SME exchange NPEX. Based in Amsterdam, Icecat Capital focuses on investing in high-potential SaaS and platform ventures across Europe, with a particular emphasis on e-commerce, digital infrastructure, and scalable B2B solutions.  Icecat Capital targets early-stage and growth-stage companies that demonstrate strong product-market fit and sustainable growth potential. The fund is especially interested in ventures that enhance digital commerce ecosystems, including areas such as: • Product Information Management (PIM) • Electronic Data Interchange (EDI) • Cloud-based SaaS platforms • Marketplace infrastructure • AI-driven content and data services

Bitdefender Voyager Ventures, established by global cybersecurity leader Bitdefender, is an early-stage investment initiative focused on startups in cybersecurity, automation, and data-driven technologies. Investing at the Seed and Series A stages, Bitdefender Voyafer Ventures supports companies developing innovative solutions to real-world challenges and preparing for sustainable growth. Beyond capital, Bitdefender Voyager Ventures leverages Bitdefender’s expertise, technologies, and global ecosystem of partners to help portfolio companies build credibility, earn trust, and deliver transformative technologies to their customers.

Aletra Capital Partners B.V. is a hands-on investment company focused on corporate divestures of non-core business units, family owned businesses with succession issues and/or stand-alone companies requiring turnaround management or growth acceleration. In Singapore we focus on young ventures looking for a bridge financing or (pre) Serie financing.

Arches Capital is a fast-growing group of business angels that is bridging the gap between Venture Capitalist (VCs) and how angels operate today, by joining the best of both worlds for our members. Our community strives to bring superior deal flow, professional knowledge and lower risk profile to our participating angel investors. We further distinguish ourselves in the way profits are generated and shared, and how our angels interact with their investees (the startups) and with each other. For this we are building the leading platform of actively engaged business angels that know how to operate and manage their investments in a professional and standardized manner. Operate like a VC, be an Angel We source, select and invest like a VC; We engage, care and inspire as the angel we are. Arches Capital invests in early stage and scaling companies. We differentiate itself from angel syndicates or funds by supporting the next growth stage as well: we aim to lead or contribute to follow-on investments of our successful portfolio companies.

Horizon 3 is an innovation platform dedicated to high-tech startups within the biobased economy. Focused on fostering sustainable growth, Horizon 3 provides crucial support and resources to pioneering entrepreneurs developing innovative solutions that leverage biological materials and processes. By creating a collaborative environment, Horizon 3 enables startups to accelerate their research, development, and commercialization efforts. The platform connects emerging companies with industry experts, investors, and strategic partners, facilitating knowledge exchange and driving technological advancements. Horizon 3's commitment to sustainability and innovation positions it as a key player in the transition towards a biobased economy. Through their efforts, they aim to transform industries, reduce environmental impact, and promote a circular economy, ensuring a more sustainable future.

EVO Venture Partners specializes in backing game-changing early-stage startups focused on software-based infrastructures, with a particular emphasis on security, storage, virtualization, and networking. With a strategic approach to investing in technological innovation, EVO Venture Partners identifies promising startups poised to disrupt and lead in their respective fields. By providing crucial early-stage capital and strategic guidance, EVO Venture Partners supports entrepreneurs in scaling their innovations and navigating competitive markets. The firm's investment strategy is rooted in its deep expertise and network within the technology sector, enabling them to nurture and accelerate the growth of portfolio companies. EVO Venture Partners actively seeks startups that demonstrate potential for transformative impact, leveraging advancements in software and infrastructure to address critical challenges in security, data storage, and network optimization. Committed to driving forward the next generation of technological solutions, EVO Venture Partners plays a pivotal role in shaping the future of software-based infrastructure through strategic investment and partnership

The Innovatiefonds Noord-Holland supports SMEs and startups in the Province of North Holland with financing for early-stage innovation. We provide convertible loans for Proof-of-Concept projects up to 350,000 euros, enabling entrepreneurs to bring their innovative ideas to fruition. The fund was established by the Province of North Holland, UvA Ventures Holding BV, Vrije Universiteit, AMC Ventures Holding BV, HvA Ventures Holding BV, and Sanquin Innovatie BV, and is supported by Europe via the European Regional Development Fund and the RVO. Our aim is to foster a thriving ecosystem for innovation by providing essential financial resources and strategic support

Esperante, a corporate venture capital firm affiliated with a global life science group, boasts leadership with deep operational expertise in the development, manufacturing, and global marketing of prescription pharmaceuticals and in vitro clinical diagnostic tests. Since its establishment in 2004, Esperante has strategically invested in 24 pharmaceutical and diagnostic companies across the US, UK, continental Europe, and Israel. Notably, the firm has achieved three successful exits: Thiakis to Wyeth/Pfizer, Pinnacle Biologics to Concordia, and Haemostatix to Ergomed. Currently, four portfolio companies are publicly listed in the US, Canada, and UK, with a focus on therapeutics in advanced clinical stages and diagnostics companies entering the European market. Esperante pursues initial investments of up to EUR 2,000,000 per venture in collaboration with other investors, aiming for exits through sales or liquidity events within a three-year timeframe.

Prime Ventures is a premier venture capital firm specializing in investing in European companies within the technology and related industries. Leveraging its substantial capital, extensive experience, and expansive network, Prime Ventures actively supports portfolio companies on their path to becoming global category leaders. The firm has a strong track record of investments across the Benelux countries, United Kingdom, France, Finland, and Sweden. With offices strategically located in The Netherlands and the UK, Prime Ventures operates as an independent partnership managing over 750 million euros in committed capital. By partnering closely with visionary entrepreneurs and providing strategic guidance, Prime Ventures catalyzes growth and innovation, shaping the future of technology across Europe.

Within the business climate around knowledge centres UG/UMCG there is an increase of start-ups and initiatives to investigate the possibilities there to. The most promising companies will at a certain moment search for venture capital to finance their growth. Carduso Capital wants to participate in this type of companies by putting in, besides capital, also their strategic knowledge. Carduso Capital recognises the several development stages of this type of companies.

TIIN Capital is a prominent venture capital firm based in the Netherlands, specializing in early-stage investments in innovative technology startups. Founded in 2000, TIIN Capital focuses on supporting entrepreneurs and companies that are developing disruptive technologies and scalable business models. The firm's investment strategy covers a wide range of sectors, including technology, life sciences, sustainability, and digital transformation. TIIN Capital typically invests in companies that demonstrate strong growth potential, innovative solutions, and a clear path to market leadership.

The Salamander Investment Network (SIN) is a vibrant community comprising over 150 INSEAD Alumni based in the Netherlands, united by their passion for early-stage startup investing. SIN fosters a supportive ecosystem for INSEAD alumni interested in entrepreneurship and venture capital. The network actively identifies and invests in promising early-stage ventures that align with their collective expertise, connections, and financial resources. SIN plays a pivotal role in nurturing these startups, providing strategic guidance, valuable industry connections, and crucial funding to help them achieve growth and success. By leveraging the diverse skills and experiences of its members, SIN aims to create lasting impact in the startup ecosystem, contributing to innovation and economic development. The network's collaborative approach and commitment to supporting entrepreneurial endeavors make it a pivotal player in the Dutch startup investment landscape.